Showing 3081-3090 of 7509 results for "".
Galderma's Differin Goes OTC, CoolSculpting Approved for Upper Arms, ZO Skin Acquires ReFissa
https://practicaldermatology.com/series/dermwire-tv/galderma-s-differin-goes-otc-coolsculpting-approved-for-upper-arms-zo-skin-acquires-refissa/18549/Galderma's Differin Gel formulation of adapalene 0.1% is now available over the counter at major retail and drug stores in the US. ZELTIQ® Aesthetics' CoolSculpting is now FDA-cleared for fat reduction in the upper arms. ZO Skin Health has acquired the worldwide rights to ReFissa from Suneva MedicalHumphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needsHow Do Dermatologists Handle “No-Show Appointments”?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/how-do-dermatologists-handle-no-show-appointments/20892/An online survey of dermatologists across the US is enlightening.Julie Harper, MD, Reacts to New Report on Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/julie-harper-md-reacts-new-report-acne-products-benzoyl-peroxide-bpo/24172/In this video, Julie Harper, MD, a dermatologist with the Dermatology and Skin Care Center of Birmingham, AL, provides her thoughts on the recent Valisure report showing that some common acne products with benzoyl peroxide (BPO) may contain benzene. She says she’s been an “avid prescriber” of acne pNew Topical Options for Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-topical-options-for-psoriasis/19979/Leon Kircik, MD shares his excitement about new molecules for psoriasis. He discusses the available data for tapinarof, a first-in-class small-molecule topical therapeutic aryl hydrocarbon receptor (AhR)–modulating agent, and roflumilast cream, a once-daily topical formulation of roflumilast, a highThe Complete Guide to Launching a New Treatment
https://practicaldermatology.com/topics/practice-management/the-complete-guide-to-launching-a-new-treatment/23551/Learn how one cosmetic dermatology office successfully launched more than 40 new treatments in 2020 with plans to double that number by the end of 2021.Molluscum: Challenges and a Promising Solution
https://practicaldermatology.com/topics/rare-disease/molluscum-challenges-and-a-promising-solution/23532/Molluscum is under-diagnosed and under-treated in the US, but a new treatment could change that.Aerolase NeoElite: A New Way to Address and Eradicate All Types of Acne
https://practicaldermatology.com/topics/acne-rosacea/aerolase-neoelite-a-new-way-to-address-and-eradicate-all-types-of-acne/23223/The Best Tax Treatment for a Dermatology Practice
https://practicaldermatology.com/topics/practice-management/the-best-tax-treatment-for-a-dermatology-practice/23144/S Corp or C Corp in the post-TCJA world?The Shape of Atopic Dermatitis
https://practicaldermatology.com/columns/clinical-focus-1/the-shape-of-atopic-dermatitis/23037/What do we really mean when we talk about flares or waxing and waning presentations?